Recuon is a clinical stage biotech company dedicated to developing novel therapeutics to tackle unmet medical needs. The company was established in December 2021, a spin-off company of Boryung Pharmaceutical which is a top listed pharmaceutical company in South Korea. Recuon is pursuing an innovative new drug development in oncology area.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2021
Main Therapeutic Focus:
Oncology
Lead Product in Development:
BR101801
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
